Washington: An enzyme, which is known for its role in heart disease, could be a promising target to treat asthma, a new study suggests. Researchers from the University of Iowa have found that the enzyme, called CaMKII, is linked to the harmful effects of oxidation in the respiratory tract, triggering asthmatic symptoms. The finding could lead to the development of a drug that would target the CaMKII enzyme, the researchers said.Asthma affects billions of people worldwide, and current treatments don`t work well, Mark Anderson, professor and chair in internal medicine at the UI and a co-corresponding author on the paper, said.
Women on testosterone therapy have improved memory: Study
Virus fears, Mecca work downsizes Saudi hajj pilgrimage